(March 2025) MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022)
A pesar de ello, su uso no se recomienda en pacientes con neoplasia endocrina mltiple (MEN-2), antecedentes de cncer medular de tiroides, enfermedad heptica, embarazadas y lactantes, y se debe usar con precaucin en pacientes con antecedentes de colelitiasis, pancreatitis o enfermedad inflamatoria intestinal (10)
& Jenuwein, T
Jackson, R
Severe vitamin A deficiency in animal models results in birth defects to these structures
Jollow DJ, Mitchell JR, Potter WC, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis